GBP2 and acute myeloid leukemia: Along the same line, Li et al. have recently observed that AML cell-derived small EVs—which are highly enriched in miR-221-3p—target Gbp2 gene expression on other AML blasts to promote AML cell proliferation and leukaemogenesis by accelerating cell cycle entry and inhibiting apoptosis on their own [49].